0000904454-13-000770.txt : 20130702
0000904454-13-000770.hdr.sgml : 20130702
20130702170036
ACCESSION NUMBER: 0000904454-13-000770
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130701
FILED AS OF DATE: 20130702
DATE AS OF CHANGE: 20130702
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Esperion Therapeutics, Inc.
CENTRAL INDEX KEY: 0001434868
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 46701 COMMERCE CENTER DRIVE
CITY: PLYMOUTH
STATE: MI
ZIP: 48170
BUSINESS PHONE: 734-862-4840
MAIL ADDRESS:
STREET 1: 46701 COMMERCE CENTER DRIVE
CITY: PLYMOUTH
STATE: MI
ZIP: 48170
FORMER COMPANY:
FORMER CONFORMED NAME: HDL THERAPEUTICS INC
DATE OF NAME CHANGE: 20080513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DP VII ASSOCIATES LP
CENTRAL INDEX KEY: 0001372932
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35986
FILM NUMBER: 13949518
BUSINESS ADDRESS:
STREET 1: ONE PALMER SQ
STREET 2: STE 515
CITY: PRINCETON
STATE: NJ
ZIP: 08542
MAIL ADDRESS:
STREET 1: ONE PALMER SQ
STREET 2: STE 515
CITY: PRINCETON
STATE: NJ
ZIP: 08542
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2013-07-01
0001434868
Esperion Therapeutics, Inc.
ESPR
0001372932
DP VII ASSOCIATES LP
C/O DOMAIN ASSOCIATES, LLC
ONE PALMER SQUARE
PRINCETON
NJ
08542
0
0
1
0
Common Stock
2013-07-01
4
C
0
30462
A
30462
D
Common Stock
2013-07-01
4
P
0
4791
14.00
A
35253
D
Series A Preferred Stock
2013-07-01
4
C
0
30462
0
D
Common Stock
30462
0
D
Warrant to Purchase Series A Preferred Stock
1.00
2013-07-01
4
J
0
8346
0
D
Series A Preferred Stock
8346
0
D
Warrant to Purchase Common Stock
6.99
2013-07-01
4
J
0
1193
0
A
2018-02-12
Common Stock
1193
1193
D
All outstanding shares of Series A Preferred Stock were automatically converted into Common Stock upon the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration.
Upon the closing of the IPO the Warrants to purchase Series A Preferred Stock automatically converted on a 6.986-for-1 basis into Warrants to purchase Common Stock, and the exercise price automatically adjusted to $6.99 per share, pursuant to the terms of such Warrants. This transaction is reported on Form 4 solely for the purpose of reflecting such changes.
The Warrant is immediately exercisable.
/s/Kathleen K. Schoemaker, Managing Member of One Palmer Square Associates VII, LLC, General Partner of DP VII Associates, L.P.
2013-07-02